Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 4,993-5,004 of 10,612
Drug study icon
CompletedNCT00114686

Quetiapine Fumarate (SEROQUEL®) for Bipolarity

This study is completed in the United States. It is testing Quetiapine Fumarate (SEROQUEL®) for Bipolarity.

In United States
BipolarityDrugA study involving a medication or substance.From 21 Years to 60 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
TerminatedNCT01467713

Ramelteon Sublingual for Bipolarity

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Bipolarity
Drug study icon
TerminatedNCT01467700

Ramelteon Sublingual for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for depression.

In United States
Depression, BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT00081380

Seroquel Plus Mood Stabilizer for Bipolarity

This study is completed in the United States and in Canada. It is testing seroquel Plus Mood Stabilizer for Bipolarity.

In United States
BipolarityDrugOver 18 Years
Countries
United States, Canada
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
CompletedNCT03325881

SHP465 at 6.25 mg for ADHD

This study is completed in the United States. 25 mg for ADHD.

In United States
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT00734578

SPD503 for ADHD

This study is completed in the United States. It is testing SPD503 for ADHD.

In United States
ADHDDrugFrom 6 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT00606411

Topiramate for Eating disorders

This study is completed in the United States. It is testing topiramate for Eating disorders.

In United States
Eating disordersDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Eating disorders
Drug study icon
CompletedNCT01887366

TV-1380 for Addiction

This study is completed in the United States and in Spain. It is testing TV-1380 for Addiction.

In United States
AddictionDrugFrom 18 Years to 60 Years
Countries
United States, Spain
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Addiction
Drug study icon
CompletedNCT00061802

Two Atypical Antipsychotics for schizophrenia

This study is completed in the United States, in India, and in Romania. It is testing two Atypical Antipsychotics for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, India, Romania
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.